TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
3.975
-0.035 (-0.87%)
Mar 26, 2026, 9:51 AM EDT - Market open
TriSalus Life Sciences Employees
TriSalus Life Sciences had 102 employees as of December 31, 2025. The number of employees decreased by 8 or -7.27% compared to the previous year.
Employees
102
Change (1Y)
-8
Growth (1Y)
-7.27%
Revenue / Employee
$442,657
Profits / Employee
-$683,235
Market Cap
243.69M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 102 | -8 | -7.27% |
| Dec 31, 2024 | 110 | -2 | -1.79% |
| Dec 31, 2023 | 112 | 37 | 49.33% |
| Dec 31, 2022 | 75 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| InfuSystem Holdings | 473 |
| RxSight | 461 |
| CVRx, Inc. | 223 |
| Sight Sciences | 186 |
| Electromed | 180 |
| 908 Devices | 172 |
| ClearPoint Neuro | 172 |
| Profound Medical | 162 |
TLSI News
- 8 days ago - TriSalus Life Sciences Announces Publication Demonstrating Enhanced Delivery and Immune Activation with Nelitolimod Delivered with Pressure-Enabled Drug Delivery in Liver Tumor Models - Business Wire
- 20 days ago - TriSalus Life Sciences, Inc. (TLSI) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 20 days ago - TriSalus Life Sciences Reports Fourth Quarter and Year-End 2025 Results and Reaffirms 2026 Revenue Guidance - Business Wire
- 4 weeks ago - TriSalus Life Sciences to Host Fourth Quarter 2025 Financial Results Conference Call - Business Wire
- 4 weeks ago - TriSalus Life Sciences Announces Pricing of $40.0 Million Public Offering - Business Wire
- 4 weeks ago - TriSalus Life Sciences Proposes Public Offering - Business Wire
- 6 weeks ago - TriSalus Life Sciences Appoints Veteran Healthcare Investor Michael Stansky to its Board of Directors - Business Wire
- 2 months ago - TriSalus Life Sciences Announces Preliminary Fourth Quarter and Full-Year 2025 Results and 2026 Revenue Guidance - Business Wire